United European Gastroenterology Journal

Papers
(The H4-Index of United European Gastroenterology Journal is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
195
Table of Contents173
UEG Week 2023 Oral Presentations123
Medical guidelines must not be influenced by commercial interests112
MRI Volumetric Changes in Perianal Fistulizing Crohn's Disease: Moving Toward a Novel Outcome Measure for Therapeutic Response99
UEG's prospects for the future94
Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study73
Stunned by a stone—A curious case of belly trouble73
Shedding a new light on gastric cancer screening68
Artificial intelligence: The researcher's assistant or sheep in wolf's clothing?65
Letter of Thanks for UEG Week 2022 Reviewers63
Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps52
Eosinophilic oesophagitis in Denmark: Population‐based incidence and prevalence in a nationwide study from 2008 to 201848
Nodular Regenerative Hyperplasia: Report of 82 Patients and Systematic Review of Literature46
Upcoming Treatments in Celiac Disease: From Luminal Enzymes to Oral Immune Tolerance46
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in Europ46
From Postoperative Prognosis to Preoperative Decision‐Making in IPMN45
Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta‐Analysis45
Corticosteroid Use in Childhood‐Onset Inflammatory Bowel Disease: A Nationwide Cohort Study (2006–2022)42
Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study42
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers40
Global Inflammatory Bowel Disease: Opportunities and Challenges for a New Era39
Recent developments in the management of ascites in cirrhosis39
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study39
Correction to “Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility”37
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study37
Dermatitis Herpetiformis in Celiac Disease: A Systematic Review and Meta‐Analysis36
Giant Meckel's Diverticulum Mimicking Crohn's Disease: Double‐Stricture Deception36
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management35
 35
Issue Information35
Correction to “A portrait of Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound training programs in Europe: Current practices and opportunities for improvement”34
Primary malignant melanoma of the oesophagus34
34
0.65435099601746